The unique properties of single-variable domain or heavy-chain only antibodies have revolutionized how researchers exploit antibodies to resolve essential questions in life science research and diagnostics, and even generate novel therapeutics.

In this webinar, our diverse panel of thought leaders will discuss the potential impact of VHH antibodies on life science research and touch on how these tools will transform technologies for imaging, diagnostics, and therapeutics.

This webinar will last for approximately 60 minutes.

Learn more about JIR Anti-Camelid Secondary Antibodies for nanobody development here

† Nanobody and Nanobodies are registered trademarks of Ablynx N.V.